Immune Therapeutics, Inc. (OTCQB: IMUN) made two additions to its board recently, and if experience and knowledge are said to be key indicators of effectiveness, employees and shareholders alike have reason to be elated with the news. Dr. Clifford A. Selsky and Paul Akin carry a wealth of experience in their respective areas of influence […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.